Reduced functional connectivity in early-stage drug-naive Parkinson's disease: A resting-state fMRI study

Neurobiology of Aging

Volumn 35, Issue 2, 2014, Pages 431-441

  Luo, ChunYan ^a   Song, Wei ^a   Chen, Qin ^a   Zheng, ZhenZhen ^a   Chen, Ke ^a   Cao, Bei ^a   Yang, Jing ^a   Li, JianPeng ^a   Huang, XiaoQi ^a   Gong, QiYong ^a   Shang, Hui Fang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Drug naive; Early stage; Functional connectivity; Mesolimbic regions; Parkinson's disease (PD); Resting state functional magnetic resonance imaging; Striatum

Indexed keywords

ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; FEMALE; FUNCTIONAL CONNECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RESTING STATE NETWORK;

DRUG NAIVE; EARLY STAGE; FUNCTIONAL CONNECTIVITY; MESOLIMBIC REGIONS; PARKINSON'S DISEASE (PD); RESTING-STATE FUNCTIONAL MAGNETIC RESONANCE IMAGING; STRIATUM;

ADULT; BRAIN; EARLY DIAGNOSIS; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; REST;

EID: 84887230568     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.08.018     Document Type: Article

References (73)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
2. Almeida Q.J., Frank J.S., Roy E.A., Jenkins M.E., Spaulding S., Patla A.E., Jog M.S. An evaluation of sensorimotor integration during locomotion toward a target in Parkinson's disease. Neuroscience 2005, 134:283-293.
3. Ashburner J. Afast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
4. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
5. Barnes K.A., Cohen A.L., Power J.D., Nelson S.M., Dosenbach Y.B.L., Miezin F.M., Petersen S.E., Schlaggar B.L. Identifying basal ganglia divisions in individuals using resting-state functional connectivity MRI. Front. Syst. Neurosci. 2010, 4:18.
6. Baudrexel S., Witte T., Seifried C., Wegner von F., Beissner F., Klein J.C., Steinmetz H., Deichmann R., Roeper J., Hilker R. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease. Neuroimage 2011, 55:1728-1738.
7. Bäumer T., Pramstaller P.P., Siebner H.R., Schippling S., Hagenah J., Peller M., Gerloff C., Klein C., Munchau A. Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study. Neurology 2007, 69:1976-1981.
8. Braak H., Braak E., Yilmazer D., Vos R.A.I., Jansen E.N.H., Bohl J.R., Jellinger K. Amygdala pathology in Parkinson's disease. Acta Neuropathol. 1994, 88:493-500.
9. Braak H., Del Tredici K., Rüb U., de Vos R.A.I., Jansen Steur E.N.H., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
10. Brooks D.J., Pavese N. Imaging biomarkers in Parkinson's disease. Prog. Neurobiol. 2011, 95:614-628.
11. Brück A., Aalto S., Nurmi E., Vahlberg T., Bergman J., Rinne J.O. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study. Mov. Disord. 2006, 21:958-963.
12. Chaudhuri K.R., Martinez-Martin P., Brown R.G., Sethi K., Stocchi F., Odin P., Ondo W., Abe K., MacPhee G., MacMahon D., Barone P., Rabey M., Forbes A., Breen K., Tluk S., Naidu Y., Olanow W., Williams A.J., Thomas S., Rye D., Tsuboi Y., Hand A., Schapira A.H.V. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov. Disord. 2007, 22:1901-1911.
13. Chaudhuri K.R., Odin P., Antonini A., Martinez-Martin P. Parkinson's disease: the non-motor issues. Parkinsonism Relat. Disord. 2011, 17:717-723.
14. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8:464-474.
15. Cohen M.X., Lombardo M.V., Blumenfeld R.S. Covariance-based subdivision of the human striatum using T1-weighted MRI. Eur. J. Neurosci. 2008, 27:1534-1546.
16. Cordes D., Haughton V.M., Arfanakis K., Carew J.D., Turski P.A., Moritz C.H., Quigley M.A., Meyerand M.E. Frequencies contributing to functional connectivity in the cerebral cortex in "resting-state" data. Am. J. Neuroradiol. 2001, 22:1326-1333.
17. Delaveau P., Salgado-Pineda P., Fossati P., Witjas T., Azulay J.-P., Blin O. Dopaminergic modulation of the default mode network in Parkinson's disease. Eur. Neuropsychopharmacol. 2010, 20:784-792.
18. Di Martino A., Scheres A., Margulies D.S., Kelly A.M.C., Uddin L.Q., Shehzad Z., Biswal B., Walters J.R., Castellanos F.X., Milham M.P. Functional connectivity of human striatum: a resting state fMRI study. Cereb. Cortex 2008, 18:2735-2747.
19. Dickson D.W., Fujishiro H., Orr C., DelleDonne A., Josephs K.A., Frigerio R., Burnett M., Parisi J.E., Klos K.J., Ahlskog J.E. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat. Disord. 2009, 15(suppl 3)):S1-S5.
20. Draganski B., Kherif F., Klöppel S., Cook P.A., Alexander D.C., Parker G.J.M., Deichmann R., Ashburner J., Frackowiak R.S.J. Evidence for segregated and integrative connectivity patterns in the human basal ganglia. J.Neurosci. 2008, 28:7143-7152.
21. Esposito F., Tessitore A., Giordano A., De Micco R., Paccone A., Conforti R., Pignataro G., Annunziato L., Tedeschi G. Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. Brain 2013, 136:710-725.
22. Ferrer I. Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease. Parkinsons Dis. 2011, 2011:1-13.
23. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
24. Fox M.D., Greicius M. Clinical applications of resting state functional connectivity. Front. Syst. Neurosci. 2010, 4:19.
25. Friston K.J. Functional and effective connectivity: a review. Brain Connect. 2011, 1:13-36.
26. Gallagher D.A., Schrag A. Psychosis, apathy, depression and anxiety in Parkinson's disease. Neurobiol. Dis. 2012, 46:581-589.
27. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stern M.B., Dodel R., Dubois B., Holloway R., Jankovic J., Kulisevsky J., Lang A.E., Lees A., Leurgans S., LeWitt P.A., Nyenhuis D., Olanow C.W., Rascol O., Schrag A., Teresi J.A., van Hilten J.J., LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 2008, 23:2129-2170.
28. Haber S.N. The primate basal ganglia: parallel and integrative networks. J.Chem. Neuroanat. 2003, 26:317-330.
29. Hacker C.D., Perlmutter J.S., Criswell S.R., Ances B.M., Snyder A.Z. Resting state functional connectivity of the striatum in Parkinson's disease. Brain 2012, 135:3699-3711.
30. Harding A.J., Stimson E., Henderson J.M., Halliday G.M. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 2002, 125:2431-2445.
31. Harvey A.K., Pattinson K.T.S., Brooks J.C.W., Mayhew S.D., Jenkinson M., Wise R.G. Brainstem functional magnetic resonance imaging: disentangling signal from physiological noise. J.Magn. Reson. Imaging 2008, 28:1337-1344.
32. Helmich R.C., Derikx L.C., Bakker M., Scheeringa R., Bloem B.R., Toni I. Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cereb. Cortex 2010, 20:1175-1186.
33. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. 1967. Neurology 2001, 57:S11-S26.
34. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J.Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
35. Jacob E.L., Gatto N.M., Thompson A., Bordelon Y., Ritz B. Occurrence of depression and anxiety prior to Parkinson's disease. Parkinsonism Relat. Disord. 2010, 16:576-581.
36. Jankovic J. Parkinson's disease: clinical features and diagnosis. J.Neurol. Neurosurg. Psychiatry 2008, 79:368-376.
37. Jenner P. Pharmacology of dopamine agonists in the treatment of Parkinson's disease. Neurology 2002, 58:S1-S8.
38. Katzman R., Zhang M.Y., Ouang-Ya-Qu, Wang Z.Y., Liu W.T., Yu E., Wong S.C., Salmon D.P., Grant I. AChinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J.Clin. Epidemiol. 1988, 41:971-978.
39. Kelly C., de Zubicaray G., Di Martino A., Copland D.A., Reiss P.T., Klein D.F., Castellanos F.X., Milham M.P., McMahon K. L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study. J.Neurosci. 2009, 29:7364-7378.
40. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N.Engl. J. Med. 1988, 318:876-880.
41. Klein A., Andersson J., Ardekani B.A., Ashburner J., Avants B., Chiang M.C., Christensen G.E., Collins D.L., Gee J., Hellier P., Song J.H., Jenkinson M., Lepage C., Rueckert D., Thompson P., Vercauteren T., Woods R.P., Mann J.J., Parsey R.V. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 2009, 46:786-802.
42. Koller W.C., Rueda M.G. Mechanism of action of dopaminergic agents in Parkinson's disease. Neurology 1998, 50:S11-S14.
43. Konczak J., Corcos D.M., Horak F., Poizner H., Shapiro M., Tuite P., Volkmann J., Maschke M. Proprioception and motor control in Parkinson's disease. J.Mot. Behav. 2009, 41:543-552.
44. Kwak Y., Peltier S., Bohnen N.I., Müller M.L., Dayalu P., Seidler R.D. Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson's disease. Front. Syst. Neurosci. 2010, 4:143.
45. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000, 10:120-131.
46. Lehéricy S., Ducros M., Van de Moortele P.-F., Francois C., Thivard L., Poupon C., Swindale N., Ugurbil K., Kim D.-S. Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann. Neurol. 2004, 55:522-529.
47. Levin B.E., Llabre M.M., Weiner W.J. Cognitive impairments associated with early Parkinson's disease. Neurology 1989, 39:557-561.
48. Lowe M.J., Mock B.J., Sorenson J.A. Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage 1998, 7:119-132.
49. Marek K.L., Seibyl J.P., Zoghbi S.S., Zea-Ponce Y., Baldwin R.M., Fussell B., Charney D.S., van Dyck C., Hoffer P.B., Innis R.B. [sup 123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996, 46:231-237.
50. Morrish P.K., Sawle G.V., Brooks D.J. Clinical and [18F] dopa PET findingsin early Parkinson's disease. J.Neurol. Neurosurg. Psychiatry 1995, 59:597-600.
51. Nilsson F.M., Kessing L.V., Bolwig T.G. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr. Scand. 2001, 104:380-386.
52. Nurmi E., Ruottinen H.M., Bergman J., Haaparanta M., Solin O., Sonninen P., Rinne J.O. Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study. Mov. Disord. 2001, 16:608-615.
53. Oakes T.R., Fox A.S., Johnstone T., Chung M.K., Kalin N., Davidson R.J. Integrating VBM into the General Linear Model with voxelwise anatomical covariates. Neuroimage 2007, 34:500-508.
54. Ouchi Y., Yoshikawa E., Okada H., Futatsubashi M., Sekine Y., Iyo M., Sakamoto M. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann. Neurol. 1999, 45:601-610.
55. Palmer S.J., Eigenraam L., Hoque T., McCaig R.G., Troiano A., McKeown M.J. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease. Neuroscience 2009, 158:693-704.
56. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci. 1990, 13:254-258.
57. Pavese N., Metta V., Bose S.K., Chaudhuri K.R., Brooks D.J. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 2010, 133:3434-3443.
58. Politis M., Wu K., Loane C., Quinn N.P., Brooks D.J., Oertel W.H., Bjorklund A., Lindvall O., Piccini P. Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci. Transl. Med. 2012, 4:128ra41.
59. Politis M., Wu K., Loane C., Turkheimer F.E., Molloy S., Brooks D.J., Piccini P. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010, 75:1920-1927.
60. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L.F., Wolters E.C., Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann. Neurol. 2004, 56:173-181.
61. Postuma R.B., Lang A.E., Massicotte-Marquez J., Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006, 66:845-851.
62. Remy P., Doder M., Lees A., Turjanski N., Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005, 128:1314-1322.
63. Schwarz J., Odin P., Buhmann C., Csoti I., Jost W., Wullner U., Storch A. Depression in Parkinson's disease. J.Neurol. 2011, 258:336-338.
64. Seibert T.M., Murphy E.A., Kaestner E.J., Brewer J.B. Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging. Radiology 2012, 263:226-234.
65. Skidmore F.M., Yang M., Baxter L., Deneen von K.M., Collingwood J., He G., White K., Korenkevych D., Savenkov A., Heilman K.M., Gold M., Liu Y. Reliability analysis of the resting state can sensitively and specifically identify the presence of Parkinson disease. Neuroimage 2013, 75:249-261.
66. Song X.W., Dong Z.Y., Long X.Y., Li S.F., Zuo X.N., Zhu C.Z., He Y., Yan C.G., Zang Y.F. REST: a toolkit for resting-state functional magnetic resonance imaging data processing. PLoS One 2011, 6:e25031.
67. Stone V.E., Baron-Cohen S., Calder A., Keane J., Young A. Acquired theory of mind impairments in individuals with bilateral amygdala lesions. Neuropsychologia 2003, 41:209-220.
68. Tan L.C.S. Mood disorders in Parkinson's disease. Parkinsonism Relat. Disord. 2011, 18:S74-S76.
69. Tessitore A., Hariri A.R., Fera F., Smith W.G., Chase T.N., Hyde T.M., Weinberger D.R., Mattay V.S. Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J.Neurosci. 2002, 22:9099-9103.
70. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
71. Wu T., Long X., Wang L., Hallett M., Zang Y., Li K., Chan P. Functional connectivity of cortical motor areas in the resting state in Parkinson's disease. Hum. Brain Mapp. 2011, 32:1443-1457.
72. Wu T., Long X., Zang Y., Wang L., Hallett M., Li K., Chan P. Regional homogeneity changes in patients with Parkinson's disease. Hum. Brain Mapp. 2009, 30:1502-1510.
73. Zhang M.Y., Katzman R., Salmon D., Jin H., Cai G.J., Wang Z.Y., Qu G.Y., Grant I., Yu E., Levy P. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann. Neurol. 1990, 27:428-437.